.jpg)
.jpg)
.png)
7.0 Treatment of Dyslipidemia
What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA... more
An old clinical dogma in OB/GYN was that dyslipidemia during pregnancy wouldn't have any long term implications on the developing fetus because of short exposures at 9 months. This has since been shown to be untrue. What health issues surface in children whose mothers experienced abnormally... more
Schedule: On Demand (The original live program aired on Tuesday, November 11, 2014) This edition of Lipid Insights was hosted by the Southeast Lipid Association. Program Overview The Lipid Insights Virtual Journal Club, a 60-minute CME Webcast with a live Q&A session, is... more
One of the most recurrent questions that cardiologists and lipidologists face in daily practice is how to best approach the elderly patient with dyslipidemia. Joining Dr. Alan Brown for special considerations in this population and guideline-based recommendations for management is Joyce Ross,... more
Medication Adherence: is it the Achilles Heel in your therapies for patients with dyslipidemia? Dr. Lynne Braun, nurse practitioner in the Preventive Cardiology Center and the Heart Center for Women, and Professor in the Department of Adult Health Nursing at the Rush College of Nursing in... more
Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Eugenia Gianos. Dr. Gianos is an assistant professor in the Department of Medicine and co-clinical director of the Center for the Prevention of Cardiovascular Disease at the... more
Thank you for attending the symposium Managing Dyslipidemia in Specia Populations, a collaboration between the Association of Black Cardiologists, National Hispanic Medical Association, and the National Lipid Association while in Anaheim, California on Sunday, November 12 from 6:30 - 8:00 AM. To... more
She is sitting in your office waiting room. That fat, hairy woman for whom you can pretty much guarantee her chief complaint —amenorrhea, abnormal hair growth or knee pain. You know the Pandora’s Box of diagnoses she really should be worried about: diabetes, hyperlipidemia, endometrial... more
Dr. Larry Kaskel welcomes Dr. Mary McGowan to Lipid Luminations. Dr. McGowan is Director of the Cholesterol Treatment Center at Concord Hospital and Member of the New Hampshire Childhood Obesity Expert Panel. They will be discussing Pediatric Dyslipidemia as secondary to genetics and obesity.